Table 1 Demographic and clinical data of the patients with TED-CON.

From: Evaluating the interreader agreement and intrareader reproducibility of Visual Field Defects in Thyroid Eye Disease– Compressive Optic Neuropathy

Characteristic

N (%)/Mean (range)

All

51 patients (96 eyes)

Patient demographic data

Age

58.3 ± 10.3 years (range 34–79)

Sex

 Male

16 (31.4%)

 Female

35 (68.6%)

Smoking history

 Current

23 (45.1%)

 Ex-smoker

8 (15.7%)

 None

17 (33.3%)

 Missing

3 (5.9%)

TSH-R

18.7 (0.7–110.0)

TSH (µU/mL)

3.4 (0–34.0)

Clinical data for all included eyes

BCVA (LogMAR)

0.42 LogMAR

CAS

5.6 (range: 1–8)

Intraocular pressure (mmHG)

18.2 mmHG (range:12–32)

Hertel Exopthalmometer (mm)

22.1 (range: 14–28)

RAPD

 Negative

77 (80.2%)

 Positive

17 (17.7%)

 Missing

2 (2.1%)

Optic disc oedema

 Yes

22 (22.9%)

 No

69 (71.9%)

 Missing

5 (5.2%)

Protan

 Normal

28 eyes (29.2%)

 Pathological

55 eyes (57.3%)

 Missing

13 eyes (13.5%)

Tritan

 Normal

1 eye (1%)

 Pathological

82 eyes (85.4%)

 Missing

13 (13.5%)

  1. TSH-R TSH receptor autoantibodies, TSH Thyroid-stimulating hormone, BCVA Best-corrected visual acuity, CAS Clinical activity score, RAPD Relative afferent pupillary defect